Human stanniocalcin-1 or -2 expressed in mice reduces bone size and severely inhibits cranial intramembranous bone growth

Transgenic Research

Volumn 19, Issue 6, 2010, Pages 1017-1039

  Johnston, Jennifer ^a,b   Ramos Valdes, Yudith ^a   Stanton, Lee Anne ^b   Ladhani, Sadia ^b   Beier, Frank ^b   DiMattia, Gabriel E ^a,b  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Calvaria; Stanniocalcin; Suture; Transgenic mice

Indexed keywords

GLYCOPROTEIN; HYPOCALCIN; PHOSPHATE TRANSPORTER; PRIMER DNA; RECOMBINANT PROTEIN; SIGNAL PEPTIDE; STC2 PROTEIN, HUMAN;

ANIMAL; ARTICLE; BONE DEVELOPMENT; C57BL MOUSE; CBA MOUSE; CRANIAL SUTURE; FEMALE; GENE EXPRESSION; GENETICS; GROWTH PLATE; GROWTH, DEVELOPMENT AND AGING; HUMAN; MALE; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; SKULL; TRANSGENIC MOUSE;

ANIMALS; BASE SEQUENCE; BONE DEVELOPMENT; CRANIAL SUTURES; DNA PRIMERS; FEMALE; GENE EXPRESSION; GLYCOPROTEINS; GROWTH PLATE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; OSTEOGENESIS; PHOSPHATE TRANSPORT PROTEINS; PREGNANCY; RECOMBINANT PROTEINS; SKULL;

MURINAE; MUS; MUS MUSCULUS;

EID: 78149464707     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-010-9376-7     Document Type: Article

References (74)

1. Adams C, Shapiro I (2002) The fate of the terminally differentiated chondrocyte: evidence for microenvironment regulation of chondrocyte apoptosis. Crit Rev Oral Biol Med 13: 465-473.
2. Agoston H, Khan S, James CG, Gillespie JR, Serra R, Stanton LA, Beier F (2007) C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and -independent pathways. BMC Dev Biol 7: 18.
3. Anderson H, Harmey D, Camacho N, Garimella R, Sipe J, Tague S, Bi X, Johnson K, Terkeltaub R, Millan J (2005) Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice. Am J Pathol 166: 1711-1720.
4. Atsumi T, Miwa Y, Kimata K, Ikawa Y (1990) A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ Dev 30: 109-116.
5. Barbaric I, Perry MJ, Dear TN, Rodrigues Da Costa A, Salopek D, Marusic A, Hough T, Wells S, Hunter AJ, Cheeseman M, Brown SD (2008) An ENU-induced mutation in the Ankrd11 gene results in an osteopenia-like phenotype in the mouse mutant Yoda. Physiol Genomics 32: 311-321.
6. Bellows C, Aubin J, Heersche J, Antosz M (1986) Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 38: 143-154.
7. Bloom MW, Murakami S, Cody D, Montufar-Solis D, Duke PJ (2006) Aspects of achondroplasia in the skulls of dwarf transgenic mice: a cephalometric study. Anat Rec A Discov Mol Cell Evol Biol 288: 316-322.
8. Bouvard D, Aszodi A, Kostka G, Block M, Albiges-Rizo C, Fassler R (2007) Defective osteoblast function in ICAP-1-deficient mice. Development 134: 2616-2625.
9. Bursell L, Woods A, James C, Pala D, Leask A, Beier F (2007) Src kinase inhibition promotes the chondrocyte phenotype. Arthritis Res Ther 9: R105.
10. Chang A, Jellinek D, Reddel R (2003) Mammalian stanniocalcins and cancer. Endocr Relat Cancer 10: 359-373.
11. Chang A, Cha J, Koentgen F, Reddel R (2005) The murine stanniocalcin 1 gene is not essential for growth and development. Mol Cell Biol 25: 10604-10610.
12. Chang AC, Hook J, Lemckert FA, McDonald MM, Nguyen MA, Hardeman EC, Little DG, Gunning PW, Reddel RR (2008) The murine stanniocalcin 2 gene is a negative regulator of postnatal growth. Endocrinology 149: 2403-2410.
13. Chimal-Monroy J, Diaz de Leon L (1997) Differential effects of transforming growth factors beta 1, beta 2, beta 3 and beta 5 on chondrogenesis in mouse limb bud mesenchymal cells. Int J Dev Biol 41: 91-102.
14. Conover C, Bale L, Overgaard M, Johnstone E, Laursen U, Fuchtbauer E, Oxvig C, van Deursen J (2003) Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 131: 1187-1194.
15. Davey RA, MacLean HE, McManus JF, Findlay DM, Zajac JD (2004) Genetically modified animal models as tools for studying bone and mineral metabolism. J Bone Miner Res 19: 882-892.
16. DiMattia GE, Varghese R, Wagner GF (1998) Molecular cloning and characterization of stanniocalcin-related protein. Mol Cell Endocrinol 146: 137-140.
17. Dobbie H, Unwin RJ, Faria NJ, Shirley DG (2008) Matrix extracellular phosphoglycoprotein causes phosphaturia in rats by inhibiting tubular phosphate reabsorption. Nephrol Dial Transplant 23: 730-733.
18. Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, Yu X, Rauch F, Davis SI, Zhang S, Rios H, Drezner MK, Quarles LD, Bonewald LF, White KE (2006) Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38: 1310-1315.
19. Filvaroff EH, Guillet S, Zlot C, Bao M, Ingle G, Steinmetz H, Hoeffel J, Bunting S, Ross J, Carano RA, Powell-Braxton L, Wagner GF, Eckert R, Gerritsen ME, French DM (2002) Stanniocalcin 1 alters muscle and bone structure and function in transgenic mice. Endocrinology 143: 3681-3690.
20. Gagliardi A, Kuo E, Raulic S, Wagner G, DiMattia GE (2005) Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs. Am J Physiol Endocrinol Metab 288: E92-E105.
21. Harmey D, Hessle L, Narisawa S, Johnson K, Terkeltaub R, Millan J (2004) Concerted regulation of inorganic pyrophosphate and ostepontin by akp2, enpp1 and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol 164: 1199-1209.
22. Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, Terkeltaub R, Millan JL (2002) Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci 99: 9445-9449.
23. Ishii M, Merrill A, Chan Y, Gitelman I, Rice D, Sucov H, Maxson RJ (2003) Msx2 and Twist cooperatively control the development of the neural crest-derived skeletogenic mesenchyme of the murine skull vault. Development 130: 6131-6142.
24. Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JCF, Trent JM, Staudt LM, Hudson J Jr, Boguski MS, Lashkari D, Shalon D, Botstein D, Brown PO (1999) The transcriptional program in the response of human fibroblasts to serum [see comments]. Science 283: 83-87.
25. James C, Appleton C, Ulici V, Underhill T, Beier F (2005) Microarray analyses of gene expression during chondrocyte differentiation involves novel regulators of hypertrophy. Mol Biol Cell 16: 5316-5333.
26. Jiang WQ, Chang AC, Satoh M, Furuichi Y, Tam PP, Reddel RR (2000) The distribution of stanniocalcin 1 protein in fetal mouse tissues suggests a role in bone and muscle development. J Endocrinol 165: 457-466.
27. Karsenty G (2003) The complexities of skeletal biology. Nature 423: 316-318.
28. Kawakami Y, Rodriguez-LeÛn J, JCIa Belmonte (2006) The role of TGF[beta]s and Sox9 during limb chondrogenesis. Curr Opin Cell Biol 18: 723-729.
29. Li Y, Iida K, O'Neil J, Zhang P, Li S, Frank A, Gabai A, Zambito F, Liang SH, Rosen CJ, Cavener DR (2003) PERK eIF2alpha kinase regulates neonatal growth by controlling the expression of circulating insulin-like growth factor-I derived from the liver. Endocrinology 144: 3505-3513.
30. Lightfoot PS, Swisher R, Coffin JD, Doetschman TC, German RZ (1997) Ontogenetic limb bone scaling in basic fibroblast growth factor (FGF-2) transgenic mice. Growth Dev Aging 61: 127-139.
31. Liu S, Gupta A, Quarles L (2007) Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Curr Opin Nephrol Hypertens 16: 329-335.
32. Lorenz-Depiereux B, Bastepe M, Benet-Pages A, Amyere M, Wagenstaller J, Muller-Barth U, Badenhoop K, Kaiser SM, Rittmaster RS, Shlossberg AH, Olivares JL, Loris C, Ramos FJ, Glorieux F, Vikkula M, Juppner H, Strom TM (2006) DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 38: 1248-1250.
33. Lu M, Wagner GF, Renfro JL (1994) Stanniocalcin stimulates phosphate reabsorption by flounder renal proximal tubule in primary culture. Am J Physiol 267: R1356-R1362.
34. Madsen K, Tavernini M, Yachimec C, Mendrick D, Alfonso P, Buergin M, Olson H, Antonaccio M, Thomson A, Fedorak R (1998) Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian intestine. Am J Physiol 274: G96-G102.
35. Mansfield K, Teixeira C, Adams C, Shapiro I (2001) Phosphate ions mediate chondrocyte apoptosis through a plasma membrane transporter mechanism. Bone 28: 1-8.
36. McLean W, Olsen BR (2001) Mouse models of abnormal skeletal development and homeostasis. Trends Genet 17: S38-S43.
37. McLeod M (1980) Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology 22: 299-301.
38. Mijalski T (2005) Untersuchungen zur genregulation anhand vergleichender transkriptom-proteom analysen und promotorstudien im mausmodell. Doctor of Natural Sciences Thesis, Department of Life Sciences and Psychology, Technischen Universitat Carolo-Wilhelmina zu Braunschweig, Braunschweig.
39. Mittapalli V, Prols F, Huang R, Christ B, Scaal M (2006) Avian stanniocalcin-2 is expressed in developing striated muscle and joints. Anat Embryol 211: 519-523.
40. Miyakoshi N, Richman C, Kasukawa Y, Linkhart TA, Baylink DJ, Mohan S (2001) Evidence that IGF-binding protein-5 functions as a growth factor. J Clin Invest 107: 73-81.
41. Moffatt P, Thomas G, Sellin K, Bessette MC, Lafreniere F, Akhouayri O, St-Arnaud R, Lanctot C (2007) Osteocrin is a specific ligand of the natriuretic peptide clearance receptor that modulates bone growth. J Biol Chem 282: 36454-36462.
42. Napierala D, Sam K, Morello R, Zheng Q, Munivez E, Shivdasani RA, Lee B (2008) Uncoupling of chondrocyte differentiation and perichondrial mineralization underlies the skeletal dysplasia in tricho-rhino-phalangeal syndrome. Hum Mol Genet 17: 2244-2254.
43. Nielsen L, Pedersen F, Pedersen L (2001) Expression of type III sodium-dependent phosphate transporters/retroviral receptors mRNAs during osteoblast differentiation. Bone 28: 160-166.
44. O'Brian J, Wilson I, Orton T, Pognan F (2000) Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267: 5421-5426.
45. Ohbayashi N, Shibayama M, Kurotaki Y, Imanishi M, Fujimori T, Itoh N, Takada S (2002) FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 16: 870-879.
46. Palmer G, Bonjour JP, Caverzasio J (1997) Expression of a newly identified phosphate transporter/retrovirus receptor in human SaOS-2 osteoblast-like cells and its regulation by insulin-like growth factor I. Endocrinology 138: 5202-5209.
47. Palmer G, Zhao J, Bonjour J, Hofstetter W, Caverzasio J (1999) In vivo expression of transcripts encoding to Glvr-1 phosphate transporter/retrovirus receptor during bone development. Bone 24: 1-7.
48. Palmer G, Guicheux J, Bonjour J, Caverzasio J (2000) Transforming growth factor-beta stimulates inorganic phosphate transport and expression of the type III phosphate transporter Glvr-1 in chondrogenic ATDC5 cells. Endocrinology 141: 2236-2243.
49. Quarles LD (2003) FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 285: E1-E9.
50. Raulic S, Ramos-Valdes Y, DiMattia GE (2008) Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro. J Endocrinol 197: 517-529.
51. Rowe P (2004) The wrickened pathways of Fgf23, MEPE and PHEX. Crit Rev Oral Biol Med 15: 264-281.
52. Sahar DE, Longaker MT, Quarto N (2005) Sox9 neural crest determinant gene controls patterning and closure of the posterior frontal cranial suture. Dev Biol 280: 344-361.
53. Schoor M, Schuster-Gossler K, Roopenian D, Gossler A (1999) Skeletal dysplasias, growth retardation, reduced postnatal survival, and impaired fertility in mice lacking the SNF2/SWI2 family member ETL1. Mech Dev 85: 73-83.
54. Segev O, Chumakov I, Nevo Z, Givol D, Madar-Shapiro L, Sheinin Y, Weinreb M, Yayon A (2000) Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice. Hum Mol Genet 9: 249-258.
55. Sheikh-Hamad D, Bick R, Wu G, Christensen B, Razeghi P, Poindexter B, Taegtmeyer H, Wamsley A, Padda R, Entman M, Nielsen S, Youker K (2003) Stanniocalcin-1 is a naturally occuring L-channel inhibitor in cardiomyocytes: relevance to human heart failure. AM J Physiol Heart Circ Physiol 285: H442-H448.
56. Stasko SE, Wagner GF (2001) Possible roles for stanniocalcin during early skeletal patterning and joint formation in the mouse. J Endocrinol 171: 237-248.
57. Ueda Y, Okano M, Williams C, Chen T, Georgopoulos K, Li E (2006) Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome. Development 133: 1183-1192.
58. Varghese R, Gagliardi A, Bialek P, Yee S, Wagner G, DiMattia GE (2002) Overexpression of human stanniocalcin affects growth and reproduction in transgenic mice. Endocrinology 143: 868-876.
59. Verdyck P, Wuyts W, van Hul W (2006) Genetic defects in the development of the skull vault in humans and mice. Crit Rev Eukaryot Gene Expr 16: 119-142.
60. Wagner GF, DiMattia GE (2006) The stanniocalcin family of proteins. J Exp Zoolog A Comp Exp Biol 305: 769-780.
61. Wagner G, Vozzolo B, Jaworski E, Haddad M, Kline R, Olson H, Rosen C, Davidson M, Renfro J (1997) Human stanniocalcin inhibits renal phosphate excretion in the rat. J Bone Miner Res 12: 165-171.
62. Wang G, Woods A, Sabari S, Pagnotta L, Stanton LA, Beier F (2004) RhoA/ROCK signaling suppresses hypertrophic chondrocyte differentiation. J Biol Chem 279: 13205-13214.
63. Warren S, Brunet L, Harland R, Economides A, Longaker M (2003) The BMP antagonist noggin regulates cranial suture fusion. Nature 422: 625-629.
64. White K, Larsson T, Econs M (2006) The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23. Endocr Rev 27: 221-224.
65. Woods A, Wang G, Beier F (2007) Regulation of chondrocyte differentiation by the actin cytoskeleton and adhesive interactions. J Cell Physiol 213: 1-8.
66. Wu S, Yoshiko Y, De Luca F (2006) Stanniocalcin 1 acts as a paracrine regulator of growth plate chondrogenesis. J Biol Chem 281: 5120-5127.
67. Yoshiko Y, Aubin JE (2004) Stanniocalcin 1 as a pleiotropic factor in mammals. Peptides 25: 1663-1669.
68. Yoshiko Y, Son A, Maeda S, Igarashi A, Takano S, Hu J, Maeda N (1999) Evidence for stanniocalcin gene expression in mammalian bone. Endocrinology 140: 1869-1874.
69. Yoshiko Y, Aubin JE, Maeda N (2002) Stanniocalcin 1 (STC1) protein and mRNA are developmentally regulated during embryonic mouse osteogenesis: the potential of stc1 as an autocrine/paracrine factor for osteoblast development and bone formation. J Histochem Cytochem 50: 483-492.
70. Yoshiko Y, Maeda N, Aubin J (2003) Stanniocalcin 1 stimulates osteoblast differentiation in rat calvaria cell cultures. Endocrinology 144: 4134-4143.
71. Yoshiko Y, Candeliere G, Maeda N, Aubin J (2007) Osteoblast autonomous Pi regulation via Pit1 plays a role in bone mineralization. Mol Cell Biol 27: 4465-4474.
72. Zhang K, Lindsberg PJ, Tatlisumak T, Kaste M, Olsen HS, Andersson LC (2000) Stanniocalcin: A molecular guard of neurons during cerebral ischemia. Proc Natl Acad Sci U S A 97: 3637-3642.
73. Zhang X, Ziran N, Goater J, Schwarz E, Puzas J, Rosier R, Zuscik M, Drissi H, O'Keefe R (2004) Primary murine limb bud mesenchymal cells in long-term culture complete chondrocyte differentiation: TGF-beta delays hypertrophy and PGE2 inhibits terminal differentiation. Bone 34: 809-817.
74. Zoidis E, Ghirlanda-Keller C, Gosteli-Peter M, Zapf J, Schmid C (2004) Regulation of phosphate (Pi) transport and NaPi-III transporter (Pit-1) mRNA in rat osteoblasts. J Endocrinol 181: 531-540.